The FDA this week released a warning letter it sent to UVLrx Therapeutics over issues with an unapproved study of an intravascular catheter, citing failures to obtain approval for the trial alongside a number of other violations. The federal watchdog said that concerns were raised after an inspection performed between March 27 and April 4 […]